Y*******o
发帖数: 3323 | | v**********m
发帖数: 5516 | 2 可能被收购。
10:02 AM Optimer Pharmaceuticals (OPTR) surges 18.1% following a report that
the antibiotics maker has attracted takeover interest from GlaxoSmithKline
(GSK), AstraZeneca (AZN), Cubist Pharmaceuticals (CBST) and Japan's Astellas
. Optimer hopes to fetch up to $1B in an auction, well above its market cap
of $660M. The company has one drug on the market, Dificid, which is used to
treat intestinal infections in hospitalized patients.
【在 Y*******o 的大作中提到】
: 没有新闻暴涨
| Y*******o
发帖数: 3323 | 3 o
that
GlaxoSmithKline
Astellas
cap
to
【在 v**********m 的大作中提到】
: 可能被收购。
: 10:02 AM Optimer Pharmaceuticals (OPTR) surges 18.1% following a report that
: the antibiotics maker has attracted takeover interest from GlaxoSmithKline
: (GSK), AstraZeneca (AZN), Cubist Pharmaceuticals (CBST) and Japan's Astellas
: . Optimer hopes to fetch up to $1B in an auction, well above its market cap
: of $660M. The company has one drug on the market, Dificid, which is used to
: treat intestinal infections in hospitalized patients.
|
|
